It is clear: the future is bright for myeloma patients

| Yelak Biru

The 58th American Society of Hematology meeting took place from December 1 through the 6th in San Diego, CA. The IMF’s Global Myeloma Action Network (GMAN) meeting took place the morning of Friday December 2, 2016. GMAN’s objective is to Improve the lives of myeloma patients around the world. Attended by countries such as Australia, […]

ASH 2016: Patient Perspective

| Yelak Biru

In this video, Yelak Biru provides the Patient Perspective on this year’s 58th American Society of Hematology (ASH) annual meeting, that took place from December 3–December 6, 2016 in San Diego. This year’s ASH marks Yelak’s 10th meeting. As Yelak points out, last year’s ASH was dubbed “A November to Remember,” because four new myeloma […]

Then and Now

| Yelak Biru

A diagnosis of terminal disease such as myeloma makes us question our place in the universe. It may sometimes create an emptiness and despair that may seem to only get worse with the uncertainty of treatment and outcomes. As of the 2016 58th American Society of Hematology (ASH) meeting, myeloma is not yet curable. All […]


Yelak Biru

Diagnosed at the young age of 25 with stage III multiple myeloma, Yelak Biru is a patient turned myeloma research advocate. Working with a team of medical practitioners and educating himself through support group leadership, information resources, advocacy sites, social media, and the IMF, Yelak has successfully integrated myeloma to his life for over two decades. Today, he facilitates the North Texas Myeloma Support Group.

Follow Yelak on Twitter